Doolen, Suzanne <br/><br/>
Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.  [electronic resource] 

 -  Pain  02 2018 
 - 224-238 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-6623 
<br/><br/><label>Standard No.: </label>10.1097/j.pain.0000000000001106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anilides--pharmacology<br/>Animals<br/>Central Nervous System Sensitization--drug effects<br/>Disease Models, Animal<br/>Female<br/>Fingolimod Hydrochloride--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Motor Activity--drug effects<br/>Multiple Sclerosis--chemically induced<br/>Myelin-Oligodendrocyte Glycoprotein--toxicity<br/>Neuralgia--drug therapy<br/>Organophosphonates--pharmacology<br/>Oxadiazoles--pharmacology<br/>Pain Threshold--drug effects<br/>Peptide Fragments--toxicity<br/>Receptors, Lysosphingolipid--metabolism<br/>Sphingosine-1-Phosphate Receptors<br/>Spinal Cord--metabolism<br/>Spinal Nerve Roots--drug effects<br/>Subcellular Fractions--drug effects<br/>Thiophenes--pharmacology<br/>eIF-2 Kinase--metabolism